2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on HR+ BC: Does Neoadjuvant Endocrine Combination Therapy Have a Greater Effect on ESDR vs. Monotherapy in Early Stage BC? Should We Consider MammaPrint a Guidance Tool for Precision Adjuvant Therapy?

523 views
August 6, 2020
Comments 0
Login to view comments. Click here to Login